Pharmatech debuts oncology campaign

Colorado, USA-based Pharmatech has announced the launch of a new campaign, Pharmatech 2.0, to highlight the company's focus in oncology,  along with other of its key developments that will take place in early  January 2009. The next generation of Pharmatech will feature a name  change from Pharmatech Inc to Pharmatech Oncology Inc, as well as a new  web site and emerging roles and responsibilities of the executive  leadership team.

With the start of 2009, all business will be managed under the name  Pharmatech Oncology, which the board of directors has implemented.  Anders Malm, current president, states: "there was a need in the  marketplace for better recognition of what type of business Pharmatech  was involved in. Changing from Pharmatech to Pharmatech Oncology relays  a core understanding that Pharmatech works within the cancer arena."

The leadership team at Pharmatech Oncology will also be undergoing a  transformation in roles and titles. Current chief executive Matthew  Wiener will now take over the daily business operations under the title  chairman and chief operating officer. Anders Malm, current president,  will now replace Dr Wiener as CEO. The new firm also welcomes Rob Bohacs  as the new corporate development manager.